Quidelortho saw the highest growth of 1.66% in patent filings in April and 0.99% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 1.66% and grants by 0.49%. GlobalData’s DataBook provides a comprehensive analysis of Quidelortho’s patent filings and grants. Buy the databook here.
Quidelortho has been focused on protecting inventions in United States(US) with four publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 38% filings and 33% grants. The United States(US), European Patent Office(EPO), World Intellectual Property Organization(WIPO), and China(CN) patent Office are among the top ten patent offices where Quidelortho is filings its patents. Among the top granted patent authorities, Quidelortho has 33% of its grants in United States(US), 33% in China(CN) and 33% in Spain(ES).
Becton Dickinson and Co and Noul could be the strongest competitors for Quidelortho
Quidelortho stands in second position with respect to its patent publications among its competitors.
Patents related to nanomedicine and rare diseases lead Quidelortho's portfolio
Quidelortho has the highest number of patents in nanomedicine followed by, rare diseases and nano tech. For nanomedicine, nearly 33% of patents were filed and no patents were granted in Q2 2024.
For comprehensive analysis of Quidelortho's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.